Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

Fwd: Re: [rda-covid19-clinical] Clinical Sub-Group Meeting 6 May 1.00 pm UTC

  • Creator
    Discussion
  • #104450

    Dear RDA COVID-19 Clinical Subgroup members,
    Dear RDA COVID-19 Clinical Subgroup members,
    > Thanks to all the members who attended our RDA COVID-19 Clinical
    > Subgroup weekly meeting last week on Wednesday 29 April 2020 at 1.00
    > pm UTC  and contributed to the document sent for the second release on
    > 1st May. We are grateful for your dedication to the group.
    >
    This week we will meet as agreed Wednesday 6 May 2020 at 1.00 pm UTC ;
    link to join : https://global.gotomeeting.com/join/903049133 (phone
    information below this mail)
    Here is the Agenda  :
    https://docs.google.com/document/d/1KLL5uBdG8ldNxQDiQ1IiKjXvlz6h9I9gsGd7
    Updated slides and documents will be presented presented and shared.
    Dear RDA COVID-19 Clinical Subgroup members,
    > Thanks to all the members who attended our RDA COVID-19 Clinical
    > Subgroup weekly meeting last week on Wednesday 29 April 2020 at 1.00
    > pm UTC  and contributed to the document sent for the second release on
    > 1st May. We are grateful for your dedication to the group.
    >
    This week we will meet as agreed Wednesday 6 May 2020 at 1.00 pm UTC ;
    link to join : https://global.gotomeeting.com/join/903049133 (phone
    information below this mail)
    Here is the Agenda  :
    https://docs.google.com/document/d/1KLL5uBdG8ldNxQDiQ1IiKjXvlz6h9I9gsGd7
    Updated slides and documents will be presented presented and shared.
    > Agenda points pasted in this mail for your convenience : input and
    > discussion needed for each point.
    >
    Information : We welcome Christian Ohmann as a new co-moderator of the
    sub-group. This week several co-moderators have very restricted time for
    the sub-group.
    1.
    Updates slides on where we stand (Dawei)
    2.
    Immunology aspects (Dawei) + call for immunological /imaging competence
    3.
    Recommendations for clinical trials from ECRIN and how some of them
    can complement our present document (Christian)
    4.
    Zotero file of resources (Dawei)
    5.
    Timeline (Anne)
    6.
    Comments (if any) to our previous document in 2nd release.
    7.
    Document to prepare for 3rd release [a document is available to be
    commented /amended in suggestion mode here :
    https://docs.google.com/document/d/1jwB3pIE2Sn0mo2WnrqKi-DIO0RzBkYNQR_F8… 
    – (Deadline by the end of Thursday 7 May, for release 8 May)
    8.
    Legal-ethical the clinical  sub-group wishes the legal-ethical
    sub-group to document (Anne)
    9.
    AOB
    * All members of sub-group continue to add information inWG resources
    *Please join the meeting from your computer, tablet or smartphone. *
    https://global.gotomeeting.com/join/903049133
    *You can also dial in using your phone. *
    United States: +1 (312) 757-3117
    *Access Code: 903-049-133 *
    *More phone numbers *
    Australia: +61 2 8355 1038
    Austria: +43 7 2081 5337
    Belgium: +32 28 93 7002
    Canada: +1 (647) 497-9373
    Denmark: +45 32 72 03 69
    Finland: +358 923 17 0556
    France: +33 170 950 590
    Germany: +49 892 0194 301
    Ireland: +353 15 295 146
    Italy: +39 0 291 29 46 27
    Netherlands: +31 202 251 001
    New Zealand: +64 9 913 2226
    Norway: +47 21 93 37 37
    Spain: +34 932 75 1230
    Sweden: +46 853 527 818
    Switzerland: +41 225 4599 60
    United Kingdom: +44 808 178 0872
    New to GoToMeeting? Get the app now and be ready when your first meeting
    starts:
    https://global.gotomeeting.com/install/903049133


    Dr Anne Cambon-Thomsen
    Directrice de recherche émérite au CNRS
    UMR 1027, Inserm, Univ Toulouse III – Paul Sabatier http://www.u1027.inserm.fr
    Plateforme sociétale genotoul http://societal.genotoul.fr/
    Ambassador of the Research Data Alliance (RDA) for health sciences and
    research ethics http://www.rd-alliance.org
    37 allées Jules Guesde  F-31000 Toulouse
    Tel : +33 (0)5 61 14 59 59 Mobile: +33 (0)6 79 41 13 48    Fax : +33
    (0)5 61 14 56 23   Skype: act_pro
    E-mail :

    Homepage

  • Author
    Replies
  • #129852

    Dear RDA COVID-19 Clinical Subgroup members, Dear new colleagues with
    Dear RDA COVID-19 Clinical Subgroup members, Dear new colleagues with
    competences in “imaging”
    >
    > Thanks to all the members who attended our RDA COVID-19 Clinical
    > Subgroup weekly meeting last week and contributed to the document used
    > in the third release on 8 May. We are grateful for your dedication to
    > the group.
    >
    Please join our meeting at 1.00 PM UTC Wednesday 13 May 2020 via this
    link
    https://global.gotomeeting.com/join/903049133 ; you’ll find the points
    for discussion in the rolling agenda

    .
    We have prepared a copy of our current sub-group document

    of the last release as a reference to check /complement the content of
    the next one in the new structure and, for those who were able to attend
    the webinar on May 12 (recording is available here
    ), the restructured
    google document for our section (clinical) is here

    and the pdf of the full document for a general overview is here
    .
    In addition here is the updated timeline

    What has been done by the editorial team is to take the content of our
    document (3^rd release) and propose its organisation according to the
    new structure. This has to be reviewed by our sub-group. In addition the
    restructured document contains a number of information at the top that
    you re all encouraged to read.
    Agenda points pasted in this mail for your convenience :  input and
    discussion needed for each point.:
    1. Updates on where we stand (3rd release) and new structure of the
    document (Dawei).
    2. Timeline and next steps (Anne)
    3. Comments received for our previous document (Christian)
    4. Zotero file of resources (Dawei/Young-Joo Lee
    )
    5. Nomination/volunteer for a) decision tree working group and b)
    dealing with some editorial / style questions, such as, referencing
    style, language choice, glossary contributions, etc.
    6. New contributions for imaging, other?
    7. Discuss the relevance of a use case from our sub-group
    8. Reminder : send questions to Legal-ethical sub-group using the “pose
    your question-document” here

    Waiting forward to our meeting,
    *Please join the meeting from your computer, tablet or smartphone. *
    https://global.gotomeeting.com/join/903049133
    *You can also dial in using your phone. *
    United States: +1 (312) 757-3117
    *Access Code: 903-049-133 *
    *More phone numbers *
    Australia: +61 2 8355 1038
    Austria: +43 7 2081 5337
    Belgium: +32 28 93 7002
    Canada: +1 (647) 497-9373
    Denmark: +45 32 72 03 69
    Finland: +358 923 17 0556
    France: +33 170 950 590
    Germany: +49 892 0194 301
    Ireland: +353 15 295 146
    Italy: +39 0 291 29 46 27
    Netherlands: +31 202 251 001
    New Zealand: +64 9 913 2226
    Norway: +47 21 93 37 37
    Spain: +34 932 75 1230
    Sweden: +46 853 527 818
    Switzerland: +41 225 4599 60
    United Kingdom: +44 808 178 0872
    New to GoToMeeting? Get the app now and be ready when your first meeting
    starts:
    https://global.gotomeeting.com/install/903049133


    Dr Anne Cambon-Thomsen
    Directrice de recherche émérite au CNRS
    UMR 1027, Inserm, Univ Toulouse III – Paul Sabatier http://www.u1027.inserm.fr

    Plateforme sociétale genotoul http://societal.genotoul.fr/
    Ambassador of the Research Data Alliance (RDA) for health sciences and
    research ethics http://www.rd-alliance.org
    37 allées Jules Guesde     F-31000 Toulouse
    Tel : +33 (0)5 61 14 59 59 Mobile: +33 (0)6 79 41 13 48    Fax : +33
    (0)5 61 14 56 23   Skype: act_pro
    E-mail :

    Dr Anne Cambon-Thomsen
    Directrice de recherche émérite au CNRS
    UMR 1027, Inserm, Univ Toulouse III – Paul Sabatier http://www.u1027.inserm.fr

    Plateforme sociétale genotoul http://societal.genotoul.fr/
    Ambassador of the Research Data Alliance (RDA) for health sciences and
    research ethics http://www.rd-alliance.org
    37 allées Jules Guesde  F-31000 Toulouse
    Tel : +33 (0)5 61 14 59 59 Mobile: +33 (0)6 79 41 13 48    Fax : +33
    (0)5 61 14 56 23   Skype: act_pro
    E-mail :

    Homepage

Log in to reply.